Diwali Samvat 2082 Stock Pick: Clean Science & Technology Ltd – MNCL’s Insight

Established in 2003, Clean Science & Technology is a specialty chemicals company and a global leader in most of its product segments, driven by niche, high-value offerings spanning polymer inhibitors, super-absorbents, antioxidants, and performance chemicals used across food, pharma, and personal care industries. Leveraging strong R&D capabilities in process innovation and plant engineering, the company has consistently delivered superior margins and robust growth. With ongoing capacity expansion and a widening portfolio of differentiated chemistries, Clean Science is well positioned to sustain its leadership and accelerate growth momentum.

Source: ACE Equity, MNCL Research

Price Performance

Source: ACE Equity, MNCL Research

Shareholding Pattern

Source: ACE Equity, MNCL Research

Niche Product Portfolio Driving Future Revenue:

Clean Science has set the stage for its next growth phase, driven primarily by its entry into Hindered Amine Light Stabilizers (HALS), where it stands as the sole Indian manufacturer with an estimated ~10% global market share. In addition, the company plans to introduce two new performance chemical products over the coming quarters to expand its portfolio. To support these initiatives, Clean Science is expected to invest around Rs6,000mn during FY24–26e, with the projects likely to achieve a peak asset turnover of 1.5–2x. While legacy products continue to inch upwards and enable superior margin performance; these new products will drive the next phase of growth for the company.

Global Leadership and Differentiated Edge Ensuring Market Dominance:

Clean Science enjoys a strong competitive advantage driven by its deep focus on process innovation and development of eco-friendly chemistries through proprietary catalytic technologies — many of which are niche and highly specialized. The company’s global leadership across multiple product categories, complemented by backward integration into key raw materials such as anisole, enhances cost competitiveness and operational efficiency. This integration, combined with differentiated manufacturing processes, robust R&D capabilities, higher yields, and minimal effluent generation, underpins Clean Science’s superior profitability and reinforces its dominant industry position.

Robust Financials and Strong Cash Generation Fueling Value Creation:

Clean Science is expected to deliver revenue CAGR of ~25% over FY25–28e, driven by HALS and new products. EBITDA margins are expected to moderate to ~37% as product mix evolves while EBITDA is expected to grow at ~21% CAGR during the same period. ROE is expected to bottom at 18.6% in FY26e and then rise to ~23% by FY28e. Robust cash flows are expected to drive free cash generation, with net cash projected at around ₹6.9 billion by FY28E. The healthy balance sheet and consistent cash accretion provide ample flexibility to fund both organic capacity expansions and potential inorganic growth opportunities.

Outlook & Valuation:

Clean Science stands at the cusp of its next growth cycle, with HALS commercialization and new product launches driving meaningful portfolio diversification and revenue acceleration. Backed by consistent innovation, prudent capital allocation, and high operating leverage, the company is expected to sustain strong profitability. Its structurally high RoE profile (20%+) and robust cash generation reinforce long-term value creation potential. We assign a DCF-based fair value of ₹1,220 per share, implying a 14% upside from current levels.

Exhibit 1: Key Financials (Consolidated)

Exhibit 2: Key Indicators

Source: Company Clean Science & Technology Ltd, MNCL Research

STOCK PICKS FOR SAMVAT 2082

*Closing Price as on 10-10-2025

This Diwali, turn your wishes into wealth –  
Open your MNCL Demat Account today!